This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
28-day Mortality or Sepsis
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

Objective: to clarify the predictive value of brain natriuretic peptide (BNP) in combination with neutrophil gelatinase associated lipocalin (NGAL) for the prognosis of patients with sepsis.

Provided treatments

  • Other: BNP and NGAL

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02871544. The sponsor of the trial is Southeast University, China and it is looking for 124 volunteers for the current phase.
Official trial title:
Predictive Value of Dynamic Combination of B-type Natriuretic Peptide and Neutrophil Gelatinase-associated Lipocalin for the Prognosis of Patients With Sepsis